Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
企業コードSTVN
会社名Stevanato Group SpA
上場日Jul 16, 2021
最高経営責任者「CEO」Mr. Franco Stevanato
従業員数5521
証券種類Ordinary Share
決算期末Jul 16
本社所在地Piombino Dese (Pd) Via Molinella, 17
都市PIOMBINO DESE
証券取引所NYSE Consolidated
国Italy
郵便番号35017
電話番号390499318173
ウェブサイトhttps://www.stevanatogroup.com/
企業コードSTVN
上場日Jul 16, 2021
最高経営責任者「CEO」Mr. Franco Stevanato
過去5年間の配当金総支払額は
53.45M
米ドルである。
STVN.NB Final Cash Dividend of gross EUR 0.053 paid on Jul 15, 2024 going ex on Jun 04, 2024
STVN.NB Final Cash Dividend of gross EUR 0.054 paid on Jul 17, 2023 going ex on Jun 07, 2023
STVN.NB Final Cash Dividend of gross EUR 0.051 paid on Jul 13, 2022 going ex on Jun 13, 2022